Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares

Summary by AI BETAClose X

Centessa Pharmaceuticals plc has priced a public offering of 11,627,907 American Depositary Shares at $21.50 per ADS, expecting to raise approximately $250 million in gross proceeds before expenses. The company has also granted underwriters a 30-day option to purchase up to an additional 1,744,186 ADSs. This offering, which is expected to close around November 14, 2025, will provide Centessa with additional capital to support its operations and development programs.

Disclaimer*

UK 100

Latest directors dealings